| 标题 |
Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Regional Health - Europe 作者:Katharina A. Mayer; Matthias Diebold; Eva V. Schrezenmeier; Philip F. Halloran; Susanne Haindl; et al 出版日期:2026-09-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)